Treatment with bioavailable small-molecule pharmacochaperones targeting the visual receptor rhodopsin offers a promising approach to prevent retinal photoreceptor degeneration caused by inherited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback